Abstract
To describe the management of dyslipidaemia in patients with high risk of cardiovascular disease (CVD) and patients with a history of CVD identified by screening for diabetes in general practice in Denmark, concentrating on prescription of lipid-lowering drugs. Moreover, to analyse predicting factors for starting lipid-lowering drugs related to patient and general practice characteristics. Population-based cross-sectional study with follow-up. A total of 139 general practices from three of five Danish regions, totalling 216 GPs. The study population comprised 4986 patients with a high risk of CVD and dyslipidaemia and 764 patients with a history of CVD and dyslipidaemia out of a population of 16 572 patients who completed screening for diabetes but were cleared for diabetes in the ADDITION study. Of patients with a high risk of CVD and dyslipidaemia not receiving lipid-lowering drugs at the time of screening (n = 4823), 20% started lipid-lowering therapy within the follow-up period (median 2.1 years). This percentage was 45% (n = 536) for patients with CVD and dyslipidaemia (median follow-up period 1.6 years). Age over 50, high cholesterol, impaired fasting glucose and/or impaired glucose tolerance, minor polypharmacy, use of h...Continue Reading
References
Jan 1, 1988·Journal of Clinical Epidemiology
Dec 23, 1998·Atherosclerosis·D WoodK Pyörälä
Aug 16, 2000·Scandinavian Journal of Primary Health Care·L BacklundL E Strender
Apr 11, 2001·Lancet·UNKNOWN EUROASPIRE I and II Group; European Action on Secondary Prevention by Intervention to Reduce Events
Sep 11, 2001·European Journal of Clinical Pharmacology·J LarsenL F Gram
Mar 2, 2002·Preventive Cardiology·Ezra A AmsterdamJ Douglas Kirk
Sep 24, 2002·The Annals of Pharmacotherapy·Stephen J Shalansky, Adrian R Levy
Apr 3, 2003·Journal of Public Health Medicine·Kevin CarrollJeremy Gray
Mar 31, 2004·Journal of Internal Medicine·S TonstadS Skurtveit
Sep 15, 2004·Diabetologia·J O ChristensenK Borch-Johnsen
Oct 11, 2005·Lancet·C BaigentUNKNOWN Cholesterol Treatment Trialists' (CTT) Collaborators
Nov 8, 2005·Scandinavian Journal of Primary Health Care·Karen-Dorthe Bach NielsenKirsti Malterud
Jun 20, 2007·International Journal of Clinical Practice·L R Erhardt, F D R Hobbs
Jul 9, 2008·Scandinavian Journal of Primary Health Care·Patrik MidlövBo Hedblad
Jul 9, 2008·Scandinavian Journal of Primary Health Care·Cecilia BjörkelundLauren Lissner
Nov 22, 2008·Journal of the American College of Cardiology·Edward J MillsDan Perri
Aug 4, 2009·Diabetic Medicine : a Journal of the British Diabetic Association·E-M DalsgaardA Sandbaek
Citations
Feb 23, 2011·Diabetologia·T LauritzenK Borch-Johnsen
Sep 24, 2010·BMC Family Practice·Pia KirkegaardJanus L Thomsen
Jul 31, 2012·Cardiovascular Diabetology·Heike U KrämerHermann Brenner
Dec 20, 2015·Scandinavian Journal of Primary Health Care·Petra G van PeetWouter de Ruijter
May 19, 2012·Primary Care Diabetes·Torsten LauritzenKnut Borch-Johnsen
Aug 2, 2011·International Journal of Cardiology·Tomasz TomasikByma Svatopluk
Oct 27, 2015·International Journal of Family Medicine·Benedicte Lind BarfoedJens Søndergaard
Dec 1, 2011·Scandinavian Journal of Primary Health Care·Maisa KuuselaPäivi Rautava
Dec 1, 2011·Scandinavian Journal of Primary Health Care·Lise GraversenAnnelli Sandbaek
May 31, 2012·Scandinavian Journal of Primary Health Care·Jørgen Nexøe
Apr 2, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Charlotte Gry HarmsenDorte Ejg Jarbøl
Aug 24, 2017·Diabetologia·Rebecca K SimmonsAnnelli Sandbæk
Nov 21, 2021·Scientific Reports·Laura InglinTiina Laatikainen